Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Gilbert

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
British Journal of Cancer|August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiformeM D Groves, V K Puduvalli, M R Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
British Journal of Cancer|August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiformeM D Groves, V K Puduvalli, M R Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
Pageof 5